[
  {
    "ts": "2026-01-22T02:26:49+00:00",
    "headline": "Morgan Stanley Cuts Smucker (SJM) Target After Strong Run, Flags Margin Recovery Risk",
    "summary": "The J. M. Smucker Company (NYSE:SJM) is included among the 15 Best High Yield Stocks to Buy. On January 16, Morgan Stanley downgraded The J. M. Smucker Company (NYSE:SJM) to Equal Weight from Overweight, and also cut its price target to $105 from $115. The firm said the broader US food space is heading into […]",
    "url": "https://finance.yahoo.com/news/morgan-stanley-cuts-smucker-sjm-022649573.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "0cff1464-3a74-3f1a-bdb6-81e93f66b608",
      "content": {
        "id": "0cff1464-3a74-3f1a-bdb6-81e93f66b608",
        "contentType": "STORY",
        "title": "Morgan Stanley Cuts Smucker (SJM) Target After Strong Run, Flags Margin Recovery Risk",
        "description": "",
        "summary": "The J. M. Smucker Company (NYSE:SJM) is included among the 15 Best High Yield Stocks to Buy. On January 16, Morgan Stanley downgraded The J. M. Smucker Company (NYSE:SJM) to Equal Weight from Overweight, and also cut its price target to $105 from $115. The firm said the broader US food space is heading into […]",
        "pubDate": "2026-01-22T02:26:49Z",
        "displayTime": "2026-01-22T02:26:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/702b1267bbe4da2a1ac51d91d44ff8a2",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Morgan Stanley Cuts Smucker (SJM) Target After Strong Run, Flags Margin Recovery Risk",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hVAKV.a2gaQD8b6vqPcJJg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/702b1267bbe4da2a1ac51d91d44ff8a2.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.FQqscSKgK91eKVDP3nxqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/702b1267bbe4da2a1ac51d91d44ff8a2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/morgan-stanley-cuts-smucker-sjm-022649573.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/morgan-stanley-cuts-smucker-sjm-022649573.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SJM"
            },
            {
              "symbol": "MS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T08:22:19+00:00",
    "headline": "Morgan Stanley Is Bullish on PTC Therapeutics, Inc. (PTCT) as Small-Cap Biotech Outlook Improves",
    "summary": "We recently compiled a list of the 15 High Growth Mid-Cap Stocks to Buy. PTC Therapeutics, Inc. is among the best high growth stocks. TheFly reported on January 8 that Morgan Stanley raised its price target on PTCT to $90 from $78 and reiterated an Overweight rating. The analyst stated that while large-cap biopharma faces […]",
    "url": "https://finance.yahoo.com/news/morgan-stanley-bullish-ptc-therapeutics-082219862.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "d1d1b8d3-36fe-310e-b4bc-38a14ed83f2f",
      "content": {
        "id": "d1d1b8d3-36fe-310e-b4bc-38a14ed83f2f",
        "contentType": "STORY",
        "title": "Morgan Stanley Is Bullish on PTC Therapeutics, Inc. (PTCT) as Small-Cap Biotech Outlook Improves",
        "description": "",
        "summary": "We recently compiled a list of the 15 High Growth Mid-Cap Stocks to Buy. PTC Therapeutics, Inc. is among the best high growth stocks. TheFly reported on January 8 that Morgan Stanley raised its price target on PTCT to $90 from $78 and reiterated an Overweight rating. The analyst stated that while large-cap biopharma faces […]",
        "pubDate": "2026-01-22T08:22:19Z",
        "displayTime": "2026-01-22T08:22:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/e2283f654b2aa1a9b033871d1749bb3e",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Morgan Stanley Is Bullish on PTC Therapeutics, Inc. (PTCT) as Small-Cap Biotech Outlook Improves",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BIsNYxkkSkZw9H7iY4_90Q--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e2283f654b2aa1a9b033871d1749bb3e.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8JF8zBYqEJabkz9LuHvmTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e2283f654b2aa1a9b033871d1749bb3e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/morgan-stanley-bullish-ptc-therapeutics-082219862.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/morgan-stanley-bullish-ptc-therapeutics-082219862.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MS"
            },
            {
              "symbol": "PTCT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T05:32:08+00:00",
    "headline": "5 Insightful Analyst Questions From Morgan Stanley’s Q4 Earnings Call",
    "summary": "Morgan Stanley’s fourth quarter was characterized by strong contributions from both its wealth and institutional securities businesses, resulting in a performance that exceeded Wall Street’s expectations and prompted a significant positive market reaction. Management attributed the robust quarter to accelerating asset inflows in wealth management, rising activity in investment banking, and expanding client engagement across the firm’s global footprint. CEO Ted Pick highlighted that “the firm is",
    "url": "https://finance.yahoo.com/news/5-insightful-analyst-questions-morgan-053208395.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "424fdc9e-88c7-30a2-8bf1-031f24e351fb",
      "content": {
        "id": "424fdc9e-88c7-30a2-8bf1-031f24e351fb",
        "contentType": "STORY",
        "title": "5 Insightful Analyst Questions From Morgan Stanley’s Q4 Earnings Call",
        "description": "",
        "summary": "Morgan Stanley’s fourth quarter was characterized by strong contributions from both its wealth and institutional securities businesses, resulting in a performance that exceeded Wall Street’s expectations and prompted a significant positive market reaction. Management attributed the robust quarter to accelerating asset inflows in wealth management, rising activity in investment banking, and expanding client engagement across the firm’s global footprint. CEO Ted Pick highlighted that “the firm is",
        "pubDate": "2026-01-22T05:32:08Z",
        "displayTime": "2026-01-22T05:32:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/39e5edccf7e328b27557353bd28ea1ed",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "MS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1KaGuUAOUKTkGFp7x5eabA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/39e5edccf7e328b27557353bd28ea1ed.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/13.arnkEUxELQLK.EhdW1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/39e5edccf7e328b27557353bd28ea1ed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-insightful-analyst-questions-morgan-053208395.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-insightful-analyst-questions-morgan-053208395.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MS"
            },
            {
              "symbol": "MS-PQ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T13:23:34+00:00",
    "headline": "Tesla Climbs Despite Cautious Morgan Stanley Outlook",
    "summary": "Investors eye AI and robotaxi updates ahead of earnings.",
    "url": "https://finance.yahoo.com/news/tesla-climbs-despite-cautious-morgan-132334256.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "86ef2674-3385-32a3-b0d1-70c9c3ad97ae",
      "content": {
        "id": "86ef2674-3385-32a3-b0d1-70c9c3ad97ae",
        "contentType": "STORY",
        "title": "Tesla Climbs Despite Cautious Morgan Stanley Outlook",
        "description": "",
        "summary": "Investors eye AI and robotaxi updates ahead of earnings.",
        "pubDate": "2026-01-22T13:23:34Z",
        "displayTime": "2026-01-22T13:23:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/9bc9fba5d8067cceda79846e4706c6f9",
          "originalWidth": 5704,
          "originalHeight": 3958,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0NktE20YWZBVVHyaucbOmw--~B/aD0zOTU4O3c9NTcwNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/9bc9fba5d8067cceda79846e4706c6f9.cf.webp",
              "width": 5704,
              "height": 3958,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cvFeMLenlC2gUUvI6Zo_gQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/9bc9fba5d8067cceda79846e4706c6f9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tesla-climbs-despite-cautious-morgan-132334256.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tesla-climbs-despite-cautious-morgan-132334256.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "MS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]